Those with a finger on the pulse of the US Drug Supply Chain Security Act (DSCSA) will have heard from all rooftops by now that FDA has granted all pharmaceutical Trading Partners a 12-month Stabilization
Continue …Take heed of the underscore! … or why the DSCSA Stabilization Period is not for fun
This is a brief animated summary of one of my own blog articles. It explains why trusted issuer lists are important for electronic credential verification. Music: “Francisco” by Michael Ramir C. (https://mixkit.co/free-stock-music/rock/) Find even more
This is a quick animated summary of a pretty long blog article by Georg Jürgens from Spherity. It explains why an open standardized approach to DSCSA-relevant Authorized Trading Partner (ATP) look-ups helps everyone in the
Spherity has developed an Ethereum-based credential revocation mechanism for use in the US pharmaceutical supply chain I have previously written about the importance of managing a registry of trusted issuers in the context of enterprise Self-sovereign Identity
Spherity has built an Ethereum-based trusted issuer registry for use in the US pharmaceutical supply chain SSI Trust Triangle Before we get stuck in, let’s set the scene with a quick recap on Self-sovereign Identity
DSCSA concerns 60,000 U.S. pharmaceutical supply chain actors. I presented how Spherity’s compliance app for Authorized Trading Partners (ATP) provides a solution for regulatory compliance. Watch the recording to learn more. Even if you’re not in
Continue …Credentialing for Pharmaceutical Supply Chain @ IEEE Blockchain Americas 2022
My presentation at the eIDAS Summit 2022 on Spherity’s DSCSA solution for Authorized Trading Partners (ATP) in the US pharmaceutical supply chain. Even if you’re not in pharma, this is a great example for the
Outlining the work of the Open Credentialing Initiative in establishing digital proof of identity, licensure status, and authorship using digital wallets and verifiable credentials … Continue …Closing a Key Gap in DSCSA Compliance
Working across disciplines can be confusing, not only due to professional jargon but also due to basic terminology being used interchangeably by different people or media sources. This is very true in the biomedical sphere.